Ads
related to: bristol-myers squibbswissmedica.startstemcells.com has been visited by 10K+ users in the past month
Search results
Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday?
Benzinga via AOL· 7 days agoThursday, Replimune Group Inc (NASDAQ:REPL) released topline results from the primary analysis of...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 6 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo Finance· 3 days agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer
Forbes· 6 days agoA four-week course of dual immunotherapy prior to surgery is highly effective in treating a certain...
Tech Hubs Sprout Innovation
New Jersey Business Magazine· 4 days agoThe HELIX in New Brunswick, a $2-billion life science center that aims to be a leader of translational research in New Jersey and throughout the East...
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 2 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.
Geron surges after winning first US FDA approval for blood disorder drug
Colorado Springs Gazette· 6 days agoThe health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes (MDS), a ...
A Bay Area Dealer Who Rewrote the History of Surrealism Makes Her Art Basel Debut
ARTnews· 2 days agoThese days, it is hard to imagine a time when everyone wasn’t talking about Leonora Carrington’s...
Very good news for Geron stock price: now what? | Invezz
Invezz· 6 days agoGeron Corporation (NASDAQ: GERN) stock price went vertical on Friday as investors cheered the latest...
State Drug Pricing Boards Forge Ahead With Eyes on Amgen Suit
Bloomberg Law· 3 days agoState affordability boards seeking to limit what health plans pay for prescription drugs are confident they will withstand legal challenges as Colorado battles what’s expected to be the first ...